Skip to main content
. 2015 Sep 15;2015:765364. doi: 10.1155/2015/765364

(a) CKD patients

Before paricalcitol After paricalcitol
PBMC + PHA PBMC PBMC + PHA PBMC
(10 μg/mL) (10 μg/mL)
IL-17 (pg/mL) 39 ± 6.2 <15 19 ± 3.8 <15
IL-6 (pg/mL) 66 ± 9.8 <1.4 31 ± 5.9 <1.4
IFN-γ (pg/mL) 174 ± 32.9 <1.5 78 ± 11.7 <1.5
IL-1β (pg/mL) 97 ± 13.3 <1 42 ± 4.3 <1
TNF-α (pg/mL) 202 ± 31.4 <1.6 104 ± 15.8 <1.6
NGAL (ng/mL) 78 ± 9.2 <0.1 21 ± 4.1 <0.1